Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $13.72, for a total transaction of $411,600.00. Following the completion of the transaction, the president now owns 1,576,097 shares of the company’s stock, valued at $21,624,050.84. This represents a 1.87 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Dawn Christine Maroney also recently made the following trade(s):
- On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total transaction of $408,300.00.
Alignment Healthcare Price Performance
Shares of NASDAQ:ALHC opened at $13.17 on Friday. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The company has a market cap of $2.52 billion, a P/E ratio of -17.10 and a beta of 1.50. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $15.82. The company has a 50-day moving average price of $13.19 and a 200 day moving average price of $11.76.
Institutional Investors Weigh In On Alignment Healthcare
Analysts Set New Price Targets
Several equities analysts have issued reports on ALHC shares. Stephens restated an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research note on Thursday, January 2nd. Stifel Nicolaus increased their target price on shares of Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a research note on Tuesday, January 14th. Barclays increased their target price on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 30th. Finally, UBS Group increased their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $11.88.
View Our Latest Stock Analysis on Alignment Healthcare
Alignment Healthcare Company Profile
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Featured Stories
- Five stocks we like better than Alignment Healthcare
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- How to Calculate Stock Profit
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Short Selling – The Pros and Cons
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.